PWMAI
DNTH icon

PENSION & WEALTH MANAGEMENT ADVISORS, INC.’s Dianthus Therapeutics DNTH Stock Holding History

PENSION & WEALTH MANAGEMENT ADVISORS, INC.’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1
Closed -$8 – 273
2023
Q2 		$8 Hold
1
– – ﹤0.01% 268
2023
Q1 		$8 Hold
1
– – ﹤0.01% 319
2022
Q4 		$4 Buy
+1
New +$18 ﹤0.01% 264

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s DNTH Position: Q3 2023 in Review

PENSION & WEALTH MANAGEMENT ADVISORS, INC. sold out of Dianthus Therapeutics (DNTH) in Q3 2023, closing a stake of 1 share — an estimated $8 sold.

PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in DNTH in Q4 2022 and held it in 3 quarters. The position peaked at $8 in Q2 2023. 30 funds tracked by Wall St. Rank hold DNTH as of Q3 2023.

  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. reported no remaining Dianthus Therapeutics position as of Q3 2023 after selling out during the quarter.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. sold 1 Dianthus Therapeutics share in Q3 2023, an estimated $8.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in Dianthus Therapeutics in Q4 2022 and held it in 3 quarters.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s Dianthus Therapeutics position peaked at $8 in Q2 2023.
  • 30 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2023.

Based on PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s 13F filing for Q3 2023, filed 7 Aug 2026.